Drugs / CTT1403
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03822871 | Apr 2019 → Oct 2022 | prostate cancer | Cancer Targeted Technology | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTT1403 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03822871 ↗ |
| Action | Inhibit | “A Peptidomimetic Inhibitor of Prostate Specific Membrane Antigen” NCT03822871 ↗ |